|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/18 | |
| C07K 16/30 | |||
| G01N 33/574 | |||
| A61K 39/395 | |||
| C07K 14/47 |
| (11) | Number of the document | 1563068 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03773719.4 |
| Date of filing the European patent application | 2003-11-21 | |
| (97) | Date of publication of the European application | 2005-08-17 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2003/013091 |
| Date | 2003-11-21 |
| (87) | Number | WO 2004/047863 |
| Date | 2004-06-10 |
| (30) | Number | Date | Country code |
| 10254601 | 2002-11-22 | DE |
| (72) |
SAHIN, Ugur, DE
TÜRECI, Özlem, DE
KOSLOWSKI, Michael, DE
|
| (73) |
Astellas Pharma Inc.,
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411,
JP
|
| (54) | IN TUMOREN DIFFERENTIELL EXPRIMIERTE GENPRODUKTE UND DEREN VERWENDUNG |
| GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND THE USE THEREOF |